Institutional Ownership
Cellectar Biosciences Inc
CUSIP 15117F880COM NEWCLRBQ1 2026
13D / 13G Filings
7
Schedule 13D/13G on record
Beneficial Filers
5
Distinct reporting persons
Largest Stake
6.1%
Max % of class reported
Institutional Holders
16
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
7 filings · latest Feb 13, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 13, 2026 | Bleichroeder LP | 13G/A | 4.6% | 200.0K | SEC |
| 2 | Feb 4, 2026 | Hexstone Capital LLC | 13G/A | 5.0% | 216.1K | SEC |
| 3 | Nov 14, 2025 | Bleichroeder LP | 13G | 6.1% | 200.0K | SEC |
| 4 | Aug 14, 2025 | Nantahala Capital Management, LLC | 13G/A | 0.1% | 1.1K | SEC |
| 5 | Aug 14, 2025 | Lytton Laurence W | 13G/A | 1.6% | 51.4K | SEC |
| 6 | Aug 8, 2025 | Hexstone Capital LLC | 13G | 5.6% | 150.0K | SEC |
| 7 | Jul 8, 2025 | Mitchell P. Kopin | 13G | 5.0% | 140.1K | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bleichroeder LP | 100.0K | $254.0K |
| 2 | Geode Capital Management, LLC | 52.8K | $134.1K |
| 3 | Riverview Capital Advisers, LLC | 10.4K | $50.1K |
| 4 | Sequoia Financial Advisors, LLC | 18.9K | $47.9K |
| 5 | Warberg Asset Management LLC | 13.9K | $35.3K |
| 6 | Ubs Group AG | 9.6K | $24.5K |
| 7 | Blackrock, Inc. | 4.7K | $12.1K |
| 8 | Tower Research Capital LLC (Trc) | 793 | $2.0K |
| 9 | Morgan Stanley | 510 | $1.3K |
| 10 | Td Waterhouse Canada Inc. | 63 | $154 |